India to United States: Meloxicam Export Trade Route
India has recorded 821 verified shipments of Meloxicam exported to United States, representing a combined trade value of $166.4M USD. This corridor is served by 13 active Indian exporters, with an average shipment value of $202.7K USD. The leading Indian exporter is UNICHEM LABORATORIES LIMITED, which accounts for 79% of total export value with 153 shipments worth $131.9M USD. On the buying side, UNICHEM PHARMACEUTICALS (USA) INC.. is the largest importer in United States with $86.4M USD in purchases. The top 3 suppliers — UNICHEM LABORATORIES LIMITED, CIPLA LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Meloxicam corridor is one of India's established pharmaceutical export routes, with 821 shipments documented worth a combined $166.4M USD. The route is dominated by UNICHEM LABORATORIES LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's meloxicam manufacturing sector.
Across 13 active suppliers, the average shipment value stands at $202.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with meloxicam's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 22.9%, placing it at rank #20 among India's top meloxicam export destinations globally.
On the import side, key buyers of Indian meloxicam in United States include UNICHEM PHARMACEUTICALS (USA) INC.., UNICHEM PHARMACEUTICALS (USA) INC., CIPLA USA INC UPS SUPPLY CHAIN SOLU and 21 others. UNICHEM PHARMACEUTICALS (USA) INC.. is the single largest importer with 33 shipments valued at $86.4M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ3
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#20
- Annual growth+22.9%
- Demand growth+19.4%
- Regulatory ease87/100
Top 10 Indian Meloxicam Exporters to United States
Showing top 10 of 13 Indian suppliers exporting Meloxicam to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNICHEM LABORATORIES LIMITED Avg $861.9K per shipment | 153 | $131.9M | 79.3% |
| 2 | CIPLA LIMITED Avg $53.5K per shipment | 451 | $24.1M | 14.5% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $36.5K per shipment | 136 | $5.0M | 3.0% |
| 4 | LUPIN LIMITED Avg $193.6K per shipment | 19 | $3.7M | 2.2% |
| 5 | CADILA HEALTHCARE LIMITED Avg $48.7K per shipment | 18 | $877.3K | 0.5% |
| 6 | CADILA HEALTHCARE LTD Avg $59.9K per shipment | 9 | $538.8K | 0.3% |
| 7 | IMMACULE LIFESCIENCES PRIVATE LIMITED Avg $23.7K per shipment | 8 | $189.9K | 0.1% |
| 8 | INTAS PHARMACEUTICALS LIMITED Avg $29.9K per shipment | 4 | $119.5K | 0.1% |
| 9 | XYLOPIA LABS PRIVATE LIMITED Avg $800 per shipment | 7 | $5.6K | 0.0% |
| 10 | MYLAN LABORATORIES LIMITED Avg $1.8K per shipment | 2 | $3.6K | 0.0% |
This table shows the top 10 of 13 Indian companies exporting meloxicam to United States, ranked by total trade value. The listed exporters are: UNICHEM LABORATORIES LIMITED, CIPLA LIMITED, ZYDUS LIFESCIENCES LIMITED, LUPIN LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, IMMACULE LIFESCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, XYLOPIA LABS PRIVATE LIMITED, MYLAN LABORATORIES LIMITED. UNICHEM LABORATORIES LIMITED is the dominant supplier with 153 shipments worth $131.9M USD, giving it a 79% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Showing top 10 of 13 total Indian exporters on the India to United States Meloxicam export route.
Top 10 Meloxicam Importers in United States
Showing top 10 of 24 known buyers in United States receiving Meloxicam shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian meloxicam in United States include UNICHEM PHARMACEUTICALS (USA) INC.., UNICHEM PHARMACEUTICALS (USA) INC., CIPLA USA INC UPS SUPPLY CHAIN SOLU, EVERSANA LIFE SCIENCE SERVICES, UPS SUPPLY CHAIN SOLUTIONS, among 24 total buyers. The largest importer is UNICHEM PHARMACEUTICALS (USA) INC.., accounting for $86.4M USD across 33 shipments — representing 52% of all meloxicam imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNICHEM PHARMACEUTICALS (USA) INC.. | 33 | $86.4M | 51.9% |
| 2 | UNICHEM PHARMACEUTICALS (USA) INC. | 54 | $43.9M | 26.4% |
| 3 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 383 | $22.9M | 13.8% |
| 4 | EVERSANA LIFE SCIENCE SERVICES | 153 | $6.0M | 3.6% |
| 5 | UPS SUPPLY CHAIN SOLUTIONS | 19 | $3.7M | 2.2% |
| 6 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 68 | $1.2M | 0.7% |
| 7 | UNICHEM PHARMACEUTICALS USA INC | 30 | $962.0K | 0.6% |
| 8 | UNICHEM PHARMACEUTICALS (USA), INC | 6 | $254.6K | 0.2% |
| 9 | PRIORITY HEALTHCARE DISTRIBUTION | 6 | $210.5K | 0.1% |
| 10 | UNICHEM PHARMACEUTICALS (USA) INC | 17 | $184.0K | 0.1% |
Showing top 10 of 24 Meloxicam importers in United States on this route.
Top 10 Meloxicam Formulations Imported by United States
Showing top 10 of 425 product formulations shipped on the India to United States Meloxicam route, ranked by trade value
United States imports a wide range of meloxicam formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA : MELOXICAM 15MG TABLETS (MELOXICAM USP 15MG) - 7308 BTLS X 1000 TABS — accounts for $43.4M USD across 1 shipments. There are 425 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA : MELOXICAM 15MG TABLETS (MELOXICAM USP 15MG) - 7308 BTLS X 1000 TABS | 1 | $43.4M | 26.1% |
| 2 | PHARMA : MELOXICAM 15MG TABLETS (MELOXICAM USP 15MG) - 7164 BTLS X 1000 TABS | 1 | $42.6M | 25.6% |
| 3 | MELOXICAM 15MG TABLETS 1000T Meloxicam Tablets 15 mg USP NDC Code: 2930012510 (BOTTLE OF 1000TX4836BT=4836000NOS) | 1 | $28.8M | 17.3% |
| 4 | MELOXICAM 15MG TABLETS 1000T MELOXICAM TABLETS 15 MG USPNDC CODE: 2930012510 (BOTTLE OF 1000TX2376BT=2376000NOS) | 1 | $14.1M | 8.5% |
| 5 | MELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 (INV.QTY.24528 PACK1X100S=2452800 NOS) | 3 | $3.1M | 1.9% |
| 6 | MELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 (INV.QTY.24384 PACK1X100S=2438400 NOS) | 3 | $3.1M | 1.9% |
| 7 | MELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 (INV.QTY.24480 PACK1X100S=2448000 NOS) | 2 | $3.1M | 1.9% |
| 8 | MELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 (INV.QTY.24432 PACK1X100S=2443200 NOS) | 2 | $3.1M | 1.8% |
| 9 | MELOXICAM TABS USP 7.5 MG NDC NO. 6909715812 ANDA NO. 77929 (INV.QTY.3000 PACK 1X500S=1500000 NOS) | 1 | $3.0M | 1.8% |
| 10 | MELOXICAM TABS USP 7.5 MG NDC NO. 6909715807 ANDA NO. 77929 (INV.QTY.49248PACK 1X100S=4924800 NOS) | 2 | $2.6M | 1.6% |
Showing top 10 of 425 Meloxicam formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 214 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's meloxicam exports to United States are driven primarily by a handful of large-scale manufacturers. UNICHEM LABORATORIES LIMITED with 153 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — UNICHEM LABORATORIES LIMITED, CIPLA LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 97% of total trade value on this route. The average shipment value of $202.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma : meloxicam 15mg tablets (meloxicam usp 15mg) - 7164 btls x 1000 tabs and meloxicam 15mg tablets 1000t meloxicam tablets 15 mg usp ndc code: 2930012510 (bottle of 1000tx4836bt=4836000nos), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, UNICHEM PHARMACEUTICALS (USA) INC.. is the largest importer with 33 shipments worth $86.4M USD — representing 52% of all meloxicam imports from India on this route. A total of 24 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $166.4M
- Avg. Shipment
- $202.7K
- Suppliers
- 13
- Buyers
- 24
- Transit (Sea)
- ~27 days
- Annual Growth
- +22.9%
Reverse Direction
United States → India — Meloxicam (Import)Other Meloxicam Routes
Meloxicam — Export Intelligence Video
Visual overview of India's meloxicam India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Meloxicam Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 821 shipments on this route.
Frequently Asked Questions — India to United States Meloxicam Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Meloxicam to United States?
The leading Indian exporters of Meloxicam to United States are UNICHEM LABORATORIES LIMITED, CIPLA LIMITED, ZYDUS LIFESCIENCES LIMITED. UNICHEM LABORATORIES LIMITED holds the largest market share at approximately 79% of total trade value on this route.
Q What is the total value of Meloxicam exports from India to United States?
India exports Meloxicam to United States worth approximately $166.4M USD across 821 recorded shipments. The average value per shipment is $202.7K USD.
Q Which ports does India use to ship Meloxicam to United States?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 214 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Meloxicam?
The average transit time for Meloxicam shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Meloxicam trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.9% with demand growth tracking at 19.4%. The route is ranked #20 among India's top Meloxicam export destinations globally.
Q How many suppliers are active on the India to United States Meloxicam route?
There are currently 13 active Indian suppliers exporting Meloxicam to United States. The market is moderately concentrated with UNICHEM LABORATORIES LIMITED accounting for 79% of total shipment value.
Q Who are the main importers of Meloxicam from India in United States?
The leading importers of Indian Meloxicam in United States include UNICHEM PHARMACEUTICALS (USA) INC.., UNICHEM PHARMACEUTICALS (USA) INC., CIPLA USA INC UPS SUPPLY CHAIN SOLU, EVERSANA LIFE SCIENCE SERVICES, UPS SUPPLY CHAIN SOLUTIONS. UNICHEM PHARMACEUTICALS (USA) INC.. is the largest buyer with 33 shipments worth $86.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Meloxicam.
- 2.Supplier/Buyer Matching: 13 Indian exporters and 24 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 821 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
821 Verified Shipments
13 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists